Abstract
Kay Davies is the Dr Lee's Professor of Anatomy in the Department of Physiology, Anatomy and Genetics, and Director of the MRC Functional Genomics Unit at the University of Oxford, UK. Her research interests lie in the molecular analysis and development of treatment for human genetic disease, particularly, Duchenne muscular dystrophy (DMD) and the application of genomics for the analysis of neurological disorders and gene–environment interactions. She is co-founder of a company, Summit Therapeutics, which aims to deliver utrophin modulation to the clinic for the therapy of DMD, which currently has a drug in Phase 1 trials. She has published more than 400 papers and won numerous awards for her work. She is a founding fellow of the UK Academy of Medical Sciences and was elected a Fellow of the Royal Society in 2003. She has been a Governor of the Wellcome Trust since 2008 and became Deputy Chairman in October, 2013. She was made Dame Commander of the British Empire for services to science in 2008.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
